ERBB2 and breast cancer: Studies performed by Gorbatenko et al. aimed to identify differences of the miRNA expression profile induced by HER2 and its truncated form p95HER2 in HER2-/p95HER2-overexpressing MCF-7 breast cancer cells [41].